Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J MacIsaac

Showing results (1-10 of 228) with videos related to

Pageof 23
Sort By:
Diabetes Care|June 20, 2025
Mind the Gap: Discordance Between Cystatin C and Creatinine eGFR and Diabetes ComplicationsRichard J MacIsaac
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 22, 2020
Dulaglutide and Insulin: How Can the AWARD Studies Help Guide Clinical Practice?Richard J MacIsaac
Future Cardiology|June 3, 2025
Semaglutide: a key medication for managing cardiovascular-kidney-metabolic syndromeRichard J MacIsaac
Future Cardiology|April 6, 2021
Glucagon-like peptide-1 receptor agonists and the cardiorenal axis in Type 2 diabetes: a focus on dulaglutideRichard J MacIsaac
Treatments in Endocrinology|April 1, 2005
Treatment of microalbuminuria in patients with type 2 diabetes mellitusGeorge Jerums, Richard J MacIsaac
World Journal of Nephrology|January 2, 2026
Cardio-kidney-metabolic protective effects of semaglutide across the spectrum of chronic kidney diseaseHarry Economos, Richard J MacIsaac
Heart, Lung & Circulation|September 3, 2010
Intensive glucose control and cardiovascular outcomes in type 2 diabetesRichard J Macisaac, George Jerums
Nature Reviews. Endocrinology|March 18, 2015
Diabetic nephropathy: How does exercise affect kidney disease in T1DM?George Jerums, Richard J MacIsaac
Current Opinion in Nephrology and Hypertension|March 23, 2011
Diabetic kidney disease with and without albuminuriaRichard J Macisaac, George Jerums
Nature Reviews. Endocrinology|May 28, 2014
Diabetes: Predicting renal function decline in patients with T2DMGeorge Jerums, Richard J MacIsaac
Pageof 23

Showing results (1-10 of 228) with videos related to

Sort By:
Pageof 23
Diabetes Care|June 20, 2025
Mind the Gap: Discordance Between Cystatin C and Creatinine eGFR and Diabetes ComplicationsRichard J MacIsaac
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 22, 2020
Dulaglutide and Insulin: How Can the AWARD Studies Help Guide Clinical Practice?Richard J MacIsaac
Future Cardiology|June 3, 2025
Semaglutide: a key medication for managing cardiovascular-kidney-metabolic syndromeRichard J MacIsaac
Future Cardiology|April 6, 2021
Glucagon-like peptide-1 receptor agonists and the cardiorenal axis in Type 2 diabetes: a focus on dulaglutideRichard J MacIsaac
Treatments in Endocrinology|April 1, 2005
Treatment of microalbuminuria in patients with type 2 diabetes mellitusGeorge Jerums, Richard J MacIsaac
World Journal of Nephrology|January 2, 2026
Cardio-kidney-metabolic protective effects of semaglutide across the spectrum of chronic kidney diseaseHarry Economos, Richard J MacIsaac
Heart, Lung & Circulation|September 3, 2010
Intensive glucose control and cardiovascular outcomes in type 2 diabetesRichard J Macisaac, George Jerums
Nature Reviews. Endocrinology|March 18, 2015
Diabetic nephropathy: How does exercise affect kidney disease in T1DM?George Jerums, Richard J MacIsaac
Current Opinion in Nephrology and Hypertension|March 23, 2011
Diabetic kidney disease with and without albuminuriaRichard J Macisaac, George Jerums
Nature Reviews. Endocrinology|May 28, 2014
Diabetes: Predicting renal function decline in patients with T2DMGeorge Jerums, Richard J MacIsaac
Pageof 23